Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist

DVAX:US

21.7400 USD 0.2400 1.09%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Dynavax Technologies Corp (DVAX)

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Contact Information

Dynavax Technologies Corp

2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753
United States
Phone: 1-510-848-5100
Fax: 1-510-450-7740

Key Executives for Dynavax Technologies Corp (DVAX)

Eddie GrayChief Executive OfficerRobert Lee CoffmanSenior VP/Chief Scientific Ofcr
David NovackSenior VP:Ops & QualityMichael S OstrachVP/CFO/Chief Bus Ofcr/Gen Cnsl
David L JohnsonVP/Chief Acctg OfficerRobert JanssenVP:Clinical Dev/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil